- Home
- XENE vs NVST Comparison
XENE vs NVST Comparison
Compare XENE & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- NVST
- Stock Information
- Founded
- XENE 1996
- NVST 2018
- Country
- XENE Canada
- NVST United States
- Employees
- XENE N/A
- NVST N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- NVST Medical/Dental Instruments
- Sector
- XENE Health Care
- NVST Health Care
- Exchange
- XENE Nasdaq
- NVST Nasdaq
- Market Cap
- XENE 3.3B
- NVST 3.3B
- IPO Year
- XENE 2014
- NVST 2019
- Fundamental
- Price
- XENE $39.73
- NVST $20.87
- Analyst Decision
- XENE Strong Buy
- NVST Hold
- Analyst Count
- XENE 7
- NVST 12
- Target Price
- XENE $57.00
- NVST $20.32
- AVG Volume (30 Days)
- XENE 440.4K
- NVST 2.3M
- Earning Date
- XENE 02-27-2025
- NVST 02-05-2025
- Dividend Yield
- XENE N/A
- NVST N/A
- EPS Growth
- XENE N/A
- NVST N/A
- EPS
- XENE N/A
- NVST N/A
- Revenue
- XENE N/A
- NVST $2,510,600,000.00
- Revenue This Year
- XENE N/A
- NVST $4.24
- Revenue Next Year
- XENE $1,599.99
- NVST $3.40
- P/E Ratio
- XENE N/A
- NVST N/A
- Revenue Growth
- XENE N/A
- NVST N/A
- 52 Week Low
- XENE $35.53
- NVST $15.15
- 52 Week High
- XENE $50.99
- NVST $23.00
- Technical
- Relative Strength Index (RSI)
- XENE 51.79
- NVST 49.55
- Support Level
- XENE $38.22
- NVST $20.42
- Resistance Level
- XENE $39.73
- NVST $22.24
- Average True Range (ATR)
- XENE 1.21
- NVST 0.76
- MACD
- XENE 0.01
- NVST -0.03
- Stochastic Oscillator
- XENE 68.12
- NVST 49.44
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.
About NVST Envista Holdings Corporation
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.